Kestra Medical Technologies, Ltd. Depreciation
Kestra Medical Technologies, Ltd. (KMTS) reported Depreciation of $2.66 million for the 3-month period ending 2026-07-31, per its 10-Q filed 2026-09-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2026-09-14
- Kestra Medical Technologies, Ltd. depreciation for the quarter ending 2026-07-31 was $2.66M, a 31.36% increase year-over-year.
- Kestra Medical Technologies, Ltd. depreciation for the quarter ending 2026-04-30 was $2.33M, a 26.63% increase year-over-year.
- Kestra Medical Technologies, Ltd. depreciation for the quarter ending 2026-01-31 was $1.98M, a 5.08% increase year-over-year.
- Kestra Medical Technologies, Ltd. depreciation for the quarter ending 2025-10-31 was $2.37M, a 26.91% increase year-over-year.
- Kestra Medical Technologies, Ltd. depreciation for fiscal 2026 was $8.71M, a 9.30% increase from fiscal 2025.
- Kestra Medical Technologies, Ltd. depreciation for fiscal 2025 was $7.97M, a 31.07% decline from fiscal 2024.
- Kestra Medical Technologies, Ltd. depreciation for fiscal 2024 was $11.56M.
| Period end | Depreciation 3 month | Depreciation 6 month | Depreciation 9 month | Depreciation 12 month |
|---|---|---|---|---|
| 2026-07-31 | $2.66M 10-Q · filed 2026-09-14 | $4.99M derived: sum of 2 quarters · filed 2026-09-14 | $6.97M derived: sum of 3 quarters · filed 2026-09-14 | $9.35M derived: sum of 4 quarters · filed 2026-09-14 |
| 2026-04-30 | $2.33M derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-14 | $4.31M derived: sum of 2 quarters · filed 2026-07-14 | $6.68M derived: sum of 3 quarters · filed 2026-07-14 | $8.71M 10-K · filed 2026-07-14 |
| 2026-01-31 | $1.98M 10-Q · filed 2026-03-17 | $4.36M derived: sum of 2 quarters · filed 2026-03-17 | $6.38M 10-Q · filed 2026-03-17 | $8.22M derived: sum of 4 quarters · filed 2026-09-14 |
| 2025-10-31 | $2.37M 10-Q · filed 2025-12-11 | $4.40M 10-Q · filed 2025-12-11 | $6.24M derived: sum of 3 quarters · filed 2026-09-14 | $8.12M derived: sum of 4 quarters · filed 2026-09-14 |
| 2025-07-31 | $2.03M 10-Q · filed 2026-09-14 | $3.86M derived: sum of 2 quarters · filed 2026-09-14 | $5.75M derived: sum of 3 quarters · filed 2026-09-14 | $7.62M derived: sum of 4 quarters · filed 2026-09-14 |
| 2025-04-30 | $1.84M derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-14 | $3.72M derived: sum of 2 quarters · filed 2026-07-14 | $5.59M derived: sum of 3 quarters · filed 2026-07-14 | $7.97M 10-K · filed 2026-07-14 |
| 2025-01-31 | $1.89M 10-Q · filed 2026-03-17 | $3.76M derived: sum of 2 quarters · filed 2026-03-17 | $6.13M 10-Q · filed 2026-03-17 | |
| 2024-10-31 | $1.87M 10-Q · filed 2025-12-11 | $4.24M 10-Q · filed 2025-12-11 | ||
| 2024-07-31 | $2.38M 10-Q · filed 2025-09-12 | |||
| 2024-04-30 | $11.56M 10-K · filed 2025-07-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |